Companies / Australia
Drug Firms Manipulating Clinical Data In Australia?
August 2006 | Company Finance AlertOne of Australia's leading cancer specialists has accused drug firms in the country of manipulating clinical trials in order to gain a commercial advantage. Professor Stephen Clarke of Sydney University, who has been conducting human clinical trials for 15 years, alleges that companies are failing to properly research the safety of their drugs and are delaying the release of negative findings.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
